611O Updated Results from BNT211-01 (NCT04503278), an Ongoing, First-in-human, Phase I Study Evaluating Safety and Efficacy of CLDN6 CAR T Cells and a CLDN6-encoding Mrna Vaccine in Patients with Relapsed/refractory CLDN6+ Solid Tumors
Annals of Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined